Figure 2.

Prescription trends of maintenance immunosuppressive agents during 2000–2009. (A) Trends of 4 classes of immunosuppressive agents. (B) Trends of two calcineurin inhibitors. (C) Trends of two antimetabolites. (D) Trends of mammalian target of rapamycin inhibitors. AZA, azathioprine; CNI, calcineurin inhibitors; CSA, cyclosporine; EVL, everolimus; MPA, mycophenolic acid; mTORi, mammalian target of rapamycin inhibitors; TAC, tacrolimus. * Indicates p-value <0.05 under the chi-square for trend